-
Mashup Score: 1PRIME® Virtual Meeting - Taking Charge of My Breast Cancer Journey: A Patient Town Hall - 24 hour(s) ago
Join us for an interactive Town Hall for patients with breast cancer and their caregivers!This program is designed to equip breast cancer patients and…
Source: primeinc.orgCategories: General Medicine News, NursingTweet
-
Mashup Score: 1
Vijayakrishna Gadi, MD, PhD, and Megan Kruse, MD, discuss the clinical benefits reported with neratinib for the treatment of patients with HER2-positive early breast cancer.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5Evolving Strategies in Adjuvant HER2+ Breast Cancer - 2 day(s) ago
Experts analyze adjuvant therapy based on preoperative responses. The discussion unveils standard practices, recent KATHERINE trial data, and considerations for residual disease, offering profound insights into tailoring treatment for improved outcomes.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Don't Rule Out Breast Cancer Surgery for 90-Year-Olds - 2 day(s) ago
Retrospective study suggests survival benefit over conservative management
Source: www.medpagetoday.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
New research suggests that racial disparities in breast cancer are driven by more than socioeconomic factors.
Source: www.mdedge.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3Exploring the Link Between Lack of Neighborhood Opportunity and Breast Cancer Mortality | Docwire News - 3 day(s) ago
Dr. Samilia Obeng-Gyasi discusses how social factors can impact outcomes in breast cancer patients.
Source: docwirenews.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 15
Study shows changing order of treatment cuts time delays and improves quality of life
Source: endeavor.moffitt.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5ESMO Deep Dive: Breast Cancer – Early Stage Triple-negative - 5 day(s) ago
This ESMO Webinar Series is available to all ESMO Members.
Source: www.esmo.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Collection Details : Oncology Times - 6 day(s) ago
Oncology Times reports essential clinical news for oncologists, hematologists and other cancer care
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 17Next-Gen PARP Inhibitor Effective in Breast Cancer - 9 day(s) ago
Abstract: New data from the PETRA clinical trial suggest that the PARP1 inhibitor saruparib induces durable responses in patients with HER-negative breast cancer. Researchers found that the maximum tolerated dose of 90 mg per day produced an overall response rate of 46.7% and median duration of response of 5.6 months. The values for a dose of 60 mg were 48.4% and 7.3 months, leading the researchers to choose this as the optimal dose.
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
Join @prime_cme and @CancerCare for an interactive townhall for patients diagnosed with #breastcancer & their caregivers on Monday, May 13. Register here: https://t.co/dByWD7Bp6J https://t.co/dLOd5xFQe3